Market Place
Sourcing Support
Sensorion Updates Audiogene Trial, Progresses SENS-501
23 Mar 2026 //
PHARMIWEB
Sensorion Releases 2025 Results, Update & Annual Report
18 Mar 2026 //
PHARMIWEB
Sensorion To Participate In ARO 49Th Midwinter Meeting
06 Feb 2026 //
PHARMIWEB
Sensorion Secures €60M Financing For Genetic Medicine Pipeline
28 Jan 2026 //
BUSINESSWIRE
Sensorion To Present At J.P. Morgan Healthcare Conference
19 Dec 2025 //
PHARMIWEB
Independent Committee Clears Sensorion`s Sens-501 Audiogene Trial
08 Dec 2025 //
PHARMIWEB
Sensorion Boosts Resources for Liquidity Contract With Kepler
15 Aug 2025 //
BUSINESSWIRE
Sensorion Fills Cohort 2 in Audiogene Ph1/2 Gene Therapy Trial
29 Jul 2025 //
BUSINESSWIRE
Sensorion Reports Positive Data from Audiogene Phase 1/2 Trial
01 Jul 2025 //
BUSINESSWIRE
Sensorion Publishes Combined Shareholders` Meeting Resolutions
13 May 2025 //
BUSINESSWIRE
Sensorion to Participate in ASGCT Annual Meeting
06 May 2025 //
BUSINESSWIRE
Sensorion Announces Pr. Natalie Loundon at 2025 ASPO Meeting
25 Apr 2025 //
BUSINESSWIRE
Sensorion Provides Documents for the Combined Shareholders Meeting
18 Apr 2025 //
BUSINESSWIRE
Sensorion to Host Symposium at ISIET Conference on April 26, 2025
16 Apr 2025 //
BUSINESSWIRE
Sensorion to Hold French Webconference for Retail Shareholders
31 Mar 2025 //
BUSINESSWIRE
Sensorion to Participate in Van Lanschot Kempen Conference - Life
26 Mar 2025 //
BUSINESSWIRE
Sensorion Completes Patient Enrollment In Ph2a NOTOXIS Trial
07 Mar 2025 //
BUSINESSWIRE
Sensorion Gets Positive DMC For SENS-501 Audiogene Ph 1/2 Trial
21 Feb 2025 //
BUSINESSWIRE
Sensorion Announces Its Participation In Several Congresses
18 Feb 2025 //
BUSINESSWIRE
Sensorion Reports Data from Audiogene Phase 1/2 Gene Therapy Trial
18 Dec 2024 //
BUSINESSWIRE
Sensorion to Present at 43rd J.P. Morgan Healthcare Conference
02 Dec 2024 //
BUSINESSWIRE
Sensorion Announces Webconference For Retail Shareholders
26 Sep 2024 //
BUSINESSWIRE
Sensorion Reports New Results At World Congress Of Audiology
23 Sep 2024 //
BUSINESSWIRE
Sensorion Announces the Availability of its Half Year 2024 Report
23 Sep 2024 //
BUSINESSWIRE
Sensorion Announces New Positive Clinical Data At Congress
20 Sep 2024 //
BUSINESSWIRE
Sensorion Reports 2024 First Half Results and Highlights Recent Updates
18 Sep 2024 //
BUSINESSWIRE
Sensorion To Participate In 59th Annual Inner Ear Biology Workshop
12 Sep 2024 //
BUSINESSWIRE
Sensorion Announces its Participation in Stifel`s Biotech Summer Summit
05 Aug 2024 //
BUSINESSWIRE
Sensorion Announces Approval to Initiate Lead Gene Therapy Candidate SENS-501
19 Jan 2024 //
BUSINESSWIRE
Sensorion Submits Trial Application for OTOF-GT, Gene Therapy Candidate
19 Jul 2023 //
BUSINESSWIRE
Sensorion Submits Trial Application for Lead Gene Therapy Candidate OTOF-GT
10 Jul 2023 //
BUSINESSWIRE
Sensorion Announces Agenda For R&D Day Showcasing Gene Therapy For Ear Disease
14 Mar 2023 //
BUSINESSWIRE
Sensorion taps Eveon to deliver gene therapy to inner ear
31 Jan 2023 //
FIERCE PHARMA
